Eden Research, a leading UK agrochemical development company, announces that Stephen O'Brien, a non- executive director of the Company, has been issued 47,059 ordinary shares at 42.5p per share, the closing mid-market price on 9 July 2008. This award of shares is in lieu of Mr O'Brien's fees and he has agreed to be locked-in for a period of 12 months from the date of issue.
Mr O'Brien holds 47,059 ordinary shares in the Company which represents 0.8% of the Company's issued share capital.
Tim Griffiths, Chief Executive, Eden Research plc
T: 01993 868844
Jonathon Brill/Caroline Stewart, Financial Dynamics
T: 020 7831 3113
About Eden Research plc
Eden Research plc is a UK publicly listed company on the PLUS Market, specialising in the development of agrochemical products and intellectual property through licensing and marketing agreements.
Eden is focused on developing products for the agricultural sector through the application of terpene chemistry and other patented environmentally friendly technologies. Eden is currently working alongside universities and partner companies in developing its product portfolio towards commercialisation.
For further information please visit www.edenresearch.com.